Cargando…

Evaluating the Release of Different Commercial Orally Modified Niacin Formulations In Vitro

Objectives: To evaluate the release profile of different modified-release oral formulations of niacin, such as immediate-release (IR) powder and tablets, timed-release (TR) caplets, extended-release (ER) capsules, and controlled-release (CR) tablets, to assure their defined release pattern and corre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chbib, Christiane, Rashid, Md. Abdur, Shah, Sarthak M., Kazi, Mohsin, Uddin, Mohammad N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386545/ https://www.ncbi.nlm.nih.gov/pubmed/37514436 http://dx.doi.org/10.3390/polym15143046

Ejemplares similares

The Autoinducer N-Octanoyl-L-Homoserine Lactone (C8-HSL) as a Potential Adjuvant in Vaccine Formulations
por: Shah, Sarthak M., et al.
Publicado: (2023)

Potential Applications of Microparticulate-Based Bacterial Outer Membrane Vesicles (OMVs) Vaccine Platform for Sexually Transmitted Diseases (STDs): Gonorrhea, Chlamydia, and Syphilis
por: Chbib, Christiane, et al.
Publicado: (2021)

Analysis of a “3-(Naphthalen-1-ylimino)indolin-2-one” Compound and Its Antimicrobial Assessment Using Lipid-Based Self-Nanoemulsifying Formulations
por: Ali Syed, Saeed, et al.
Publicado: (2020)

Biorelevant In Vitro Release Testing and In Vivo Study of Extended-Release Niacin Hydrophilic Matrix Tablets
por: Milanowski, Bartłomiej, et al.
Publicado: (2020)

Hypophosphatemic effect of niacin extended release in ischemic kidney disease
por: Yasmeen, Ghazala, et al.
Publicado: (2015)

Niacin in Maize
por: Burkholder, Paul R., et al.
Publicado: (1944)

Developing of SiO(2) Nanoshells Loaded with Fluticasone Propionate for Potential Nasal Drug Delivery: Determination of Pro-Inflammatory Cytokines through mRNA Expression
por: Mehmood, Yasir, et al.
Publicado: (2022)

Targeting mulitple dyslipidemias with fixed combinations – focus on extended release niacin and simvastatin
por: Pandian, Anbu, et al.
Publicado: (2008)

Biomimetic thiamine- and niacin-decorated liposomes for enhanced oral delivery of insulin
por: He, Haisheng, et al.
Publicado: (2018)

Formulation of Modified-Release Bilayer Tablets of Atorvastatin and Ezetimibe: An In-Vitro and In-Vivo Analysis
por: Mubeen, Iqra, et al.
Publicado: (2022)

Design and Evaluation of Niacin Microspheres
por: Maravajhala, Vidyavathi, et al.
Publicado: (2009)

Combined Curcumin and Lansoprazole-Loaded Bioactive Solid Self-Nanoemulsifying Drug Delivery Systems (Bio-SSNEDDS)
por: Alshadidi, Abdulrahman, et al.
Publicado: (2021)

Niacin in the Treatment of Hyperlipidemias in Light of New Clinical Trials: Has Niacin Lost its Place?
por: Zeman, Miroslav, et al.
Publicado: (2015)

Niacin Alternatives for Dyslipidemia: Fool’s Gold or Gold Mine? Part II: Novel Niacin Mimetics
por: Goel, Harsh, et al.
Publicado: (2016)

Niacin Alternatives for Dyslipidemia: Fool’s Gold or Gold Mine? Part I: Alternative Niacin Regimens
por: Dunbar, Richard L., et al.
Publicado: (2016)

Extended Release Niacin-Laropiprant in Patients with Hypercholesterolemia or Mixed Dyslipidemias Improves Clinical Parameters
por: Vosper, Helen
Publicado: (2011)

Safety and efficacy of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia
por: Viljoen, Adie, et al.
Publicado: (2010)

Management of complex lipid abnormalities with a fixed dose combination of simvastatin and extended release niacin
por: Robinson, Jennifer G
Publicado: (2009)

Critical appraisal of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia
por: Hussein, Ayman A, et al.
Publicado: (2010)

Review of extended-release niacin/laropiprant fixed combination in the treatment of mixed dyslipidemia and primary hypercholesterolemia
por: Parhofer, Klaus G
Publicado: (2009)

Niacin Extended Release (ER)/Simvastatin (Simcor®): A Guide to its Use in Lipid Regulation
por: Lyseng-Williamson, Katherine A.
Publicado: (2012)

Changes in Lipoprotein Particle Number With Ezetimibe/Simvastatin Coadministered With Extended‐Release Niacin in Hyperlipidemic Patients
por: Le, Ngoc‐Anh, et al.
Publicado: (2013)

The mechanism and mitigation of niacin-induced flushing
por: Kamanna, V S, et al.
Publicado: (2009)

In vitro assessment of probiotic attributes for strains contained in commercial formulations
por: Mazzantini, Diletta, et al.
Publicado: (2022)

Development of Stable Liposomal Drug Delivery System of Thymoquinone and Its In Vitro Anticancer Studies Using Breast Cancer and Cervical Cancer Cell Lines
por: Shariare, Mohammad Hossain, et al.
Publicado: (2022)

Niacin alleviates TRAIL-mediated colon cancer cell death via autophagy flux activation
por: Kim, Sung-Wook, et al.
Publicado: (2015)

Effect of Extended-Release Niacin/Laropiprant Combination on Plasma Adiponectin and Insulin Resistance in Chinese Patients with Dyslipidaemia
por: Hu, Miao, et al.
Publicado: (2015)

Niacin Reverses Migratory Macrophage Foam Cell Arrest Mediated by oxLDL In Vitro
por: Huang, Hua, et al.
Publicado: (2014)

Niacin improves maturation and cryo-tolerance of bovine in vitro matured oocytes: An experimental study
por: Kafi, Mojtaba, et al.
Publicado: (2019)

Novel Hydrolytic Degradable Crosslinked Interpenetrating Polymeric Networks (IPNs): An Efficient Hybrid System to Manage the Controlled Release and Degradation of Misoprostol
por: Mehmood, Yasir, et al.
Publicado: (2023)

Acute Liver Failure Secondary to Niacin Toxicity
por: Ellsworth, Marc A., et al.
Publicado: (2014)

Ocular Effects of Niacin: A Review of the Literature
por: Domanico, Daniela, et al.
Publicado: (2015)

Niacin Enhancement for Parkinson’s Disease: An Effectiveness Trial
por: Chong, Raymond, et al.
Publicado: (2021)

NAD(+) repletion with niacin counteracts cancer cachexia
por: Beltrà, Marc, et al.
Publicado: (2023)

Molecular identification of Mycoplasma synoviae from seroprevalent commercial breeder farms at Chittagong district, Bangladesh
por: Uddin, Md. Inkeyas, et al.
Publicado: (2016)

Effect of Extended-Release Niacin on New-Onset Diabetes Among Hyperlipidemic Patients Treated With Ezetimibe/Simvastatin in a Randomized Controlled Trial
por: Guyton, John R., et al.
Publicado: (2012)

Role of Alternative Lipid Excipients in the Design of Self-Nanoemulsifying Formulations for Fenofibrate: Characterization, in vitro Dispersion, Digestion and ex vivo Gut Permeation Studies
por: Alshamsan, Aws, et al.
Publicado: (2018)

Development and optimization of sitagliptin and dapagliflozin loaded oral self-nanoemulsifying formulation against type 2 diabetes mellitus
por: Kazi, Mohsin, et al.
Publicado: (2020)

The Effects of Extended Release Niacin in Combination with Omega 3 Fatty Acid Supplements in the Treatment of Elevated Lipoprotein (a)
por: Helmbold, Alan F., et al.
Publicado: (2010)

Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy
por: Insull, William, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_r5krvi5jq6i4at5v9hhur66jr3